CIRM Clinical Trials

Through its strategic funding of clinical trials, CIRM helps advance innovative stem cell and gene therapy discoveries toward future treatments for patients.

CIRM funds clinical trials across a broad range of diseases and conditions that include rare and genetic disorders, treatment-resistant and refractory diseases, and many forms of cancer. Our involvement in the clinical trial process is vital to transforming potential treatments into available therapies by accelerating pathways to commercialization. Visit our Funding Opportunities page to apply for clinical trial research funding.

0

CIRM-Funded Clinical Trials

Disease AreasInvestigatorOrganizationPhaseTrial StatusTarget EnrollmentDetail
Blood Cancer
Solid Tumors		 Professor Irving L Weissman MD Stanford University Phase 1 Completed 88
Brain Cancer Dr. Christine E. Brown City of Hope, Beckman Research Institute Phase 1 Active, not recruiting 82
Brain Cancer Anthony J. Gringeri ImmunoCellular Therapeutics Phase 3 Suspended 234
Brain Cancer Dr Jana Portnow City of Hope, Beckman Research Institute Phase 1 Launching N/A
Brain Cancer Dr. Reena Parada Thomas Stanford University Phase 1 Launching N/A
Brain Cancer Dr. Hideho Okada University of California, San Francisco Phase 1 Launching N/A
Brain Cancer Noriyuki Kasahara University of California, San Francisco Phase 1 Launching N/A
Brain Cancer
Breast Cancer		 Dr Saul J Priceman City of Hope, Beckman Research Institute Phase 1 Recruiting 39
Brain Cancer Dr. Leo D Wang City of Hope, Beckman Research Institute Phase 1 Recruiting 18
Brain Cancer Crystal Mackall Stanford University Phase 1 Recruiting 54
Colon Cancer Ivan King Tachyon Therapeutics, Inc Phase 1 Launching N/A
Colon Cancer Mark Chao Forty Seven Inc. Phase 1/2 Completed 78
Lung Cancer Steven M. Dubinett M.D. University of California, Los Angeles Phase 1 Active, not recruiting 24
Melanoma Robert Dillman Caladrius Biosciences Phase 3 Closed 4
Melanoma
Skin cancer		 Dr. Antoni Ribas MD/PhD University of California, Los Angeles Phase 1 Closed 5
Melanoma Anusha Kalbasi Stanford University Phase 1 Launching N/A
Sarcoma Theodore Scott Nowicki University of California, Los Angeles Phase 1 Closed 5
Solid Tumors Pei Wang Eureka Therapeutics, Inc. Phase 1/2 Launching N/A
Solid Tumors Dr. Dennis J Slamon University of California, Los Angeles Phase 1 Completed 46
Solid Tumors Dr. John Le Gall Allogene Therapeutics Phase 1 Launching N/A
Solid Tumors Dr. Pamela Reilly Contag BioEclipse Therapeutics INC. Phase 1 Recruiting 60